ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

NORTHERN TRUST CORP's Holding History (CIK: 0000073124)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 352,239 Value ($000) $5,424 Avg Close $19.92 Range $15.14 - $24.64

Q3 2025

Shares 394,452 Value ($000) $8,074 Avg Close $20.16 Range $17.43 - $24.38

Q2 2025

Shares 324,628 Value ($000) $6,512 Avg Close $18.93 Range $13.30 - $24.11

Q1 2025

Shares 338,650 Value ($000) $6,665 Avg Close $21.52 Range $18.67 - $25.37

Q4 2024

Shares 331,500 Value ($000) $7,459 Avg Close $25.92 Range $21.43 - $30.03

Q3 2024

Shares 304,396 Value ($000) $7,774 Avg Close $23.16 Range $20.63 - $27.67

Q2 2024

Shares 227,767 Value ($000) $5,323 Avg Close $21.05 Range $15.96 - $26.00

Q1 2024

Shares 218,758 Value ($000) $3,848 Avg Close $15.34 Range $10.90 - $19.50

Q4 2023

Shares 224,812 Value ($000) $3,111 Avg Close $12.23 Range $9.80 - $15.41

Q3 2023

Shares 194,534 Value ($000) $2,657 Avg Close $16.84 Range $12.38 - $20.77

Q2 2023

Shares 195,940 Value ($000) $3,999 Avg Close $20.21 Range $17.15 - $23.98

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	352,239	$5,424	$19.92	$15.14 - $24.64
Q3 2025	394,452	$8,074	$20.16	$17.43 - $24.38
Q2 2025	324,628	$6,512	$18.93	$13.30 - $24.11
Q1 2025	338,650	$6,665	$21.52	$18.67 - $25.37
Q4 2024	331,500	$7,459	$25.92	$21.43 - $30.03
Q3 2024	304,396	$7,774	$23.16	$20.63 - $27.67
Q2 2024	227,767	$5,323	$21.05	$15.96 - $26.00
Q1 2024	218,758	$3,848	$15.34	$10.90 - $19.50
Q4 2023	224,812	$3,111	$12.23	$9.80 - $15.41
Q3 2023	194,534	$2,657	$16.84	$12.38 - $20.77
Q2 2023	195,940	$3,999	$20.21	$17.15 - $23.98